Search result · source text not verified
Resilience layoff? : r/biotech
I’m seeing a lot of posts on LinkedIn about Resilience (a CDMO) laying off people. But no news article about it. Does anyone know what happened and why? ...
Biologics CDMO drug substance & sterile drug product manufacturing, from first clinical batch to commercial supply.
Products
Process & Analytical DevelopmentAccelerate your biologics with Resilience. CDMO providing process & analytical development.
Drug Substance ManufacturingBiologics drug substance manufacturing for complex molecule production, from clinical development to commercial supply, including tech transfer & purification.
Drug Product ManufacturingSterile drug product manufacturing CDMO solutions for clinical and commercial supply. Formulation, aseptic filling, testing, & packaging services.
Fill/FinishAseptic fill/finish CDMO services for biotech & pharma. From clinical vials to commercial prefilled syringes and cartridges, ensure your product's integrity.
Device Assembly, Packing & LogisticsDrug delivery, device assembly, drug product packaging, serialization & and finished-goods logistics. Streamline sterile drug product delivery with Resilience.
No matching products or features.
Customer feedback
No feedback found.
Marketing & Ads
GoogleWBNS TV Inc.
Original ad ↗
First shown Jan 22, 2026 · Last shown Oct 22, 2026Landing page unavailable: the ad source did not supply a destination URL.
GoogleWBNS TV Inc.
Original ad ↗
First shown Jan 22, 2026 · Last shown Oct 22, 2026Landing page unavailable: the ad source did not supply a destination URL.
GoogleWBNS TV Inc.
Original ad ↗
First shown Jan 22, 2026 · Last shown Oct 22, 2026Landing page unavailable: the ad source did not supply a destination URL.
GoogleWBNS TV Inc.
Original ad ↗
First shown Jan 22, 2026 · Last shown Oct 22, 2026Landing page unavailable: the ad source did not supply a destination URL.
Website marketing
Contact Resilience | Biologics Manufacturing CDMO ↗
Explore Resilience’s services, including cell line development, viral vector manufacturing, biologics manufacturing, and analytical & process development.
Observed Nov 11, 2026
Contact Resilience | Biologics Manufacturing CDMO ↗
Explore Resilience’s services, including cell line development, viral vector manufacturing, biologics manufacturing, and analytical & process development.
Observed Nov 11, 2026
New pages
The People Behind the Process: How Resilience’s Teams Enable Flexible Biopharma Manufacturing ↗
Resilience Further Advances North American Manufacturing Strategy Transformation ↗
The Future of CDMOs: Navigating the Combinations Interview with Kothari and Jonathon Amaya-Hodges ↗
On Demand Webinar: Outsourced Pharma Capabilities Update - Large Molecule ↗
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply ↗
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities ↗
From Complexity to Clarity - Sharpening Focus for Long-Term Performance in a More Demanding CDMO Era ↗
Redefining CAR-T Speed and Strength with DAR-T™: A Conversation with Nicholas Kirian ↗
Modified Source ↗
Process & Analytical Development for Programs with GMP in Sight ↗
Modified Source ↗
Device Assembly, Packaging & Logistics for Late-Stage and Commercial Sterile Drug Products ↗
Modified Source ↗
Biologics & Sterile Drug Product Manufacturing for Biotech ↗
Modified Source ↗
Reliable Commercial Supply for Pharma ↗
Modified Source ↗
drug substance manufacturing ↗
Modified Source ↗
cdmo fill finish ↗
Modified Source ↗
drug product manufacturing ↗
Modified Source ↗
cookie preferences ↗
Modified Source ↗
our team ↗
Modified Source ↗
facilities overview ↗
Modified Source ↗
Insights on Biologics Manufacturing & Development ↗
Modified Source ↗
blog old ↗
Modified Source ↗
accelerating clinical timelines of induced pluripotent stem cells ipscs with pluristyx ↗
Modified Source ↗
executive interview advancing therapies that transform lives ↗
Modified Source ↗
meet the team viral vector development manufacturing ↗
Modified Source ↗
finish trends challenges and whats ahead ↗
Modified Source ↗
finish services outsourced pharma capacity update ↗
Modified Source ↗
finish ↗
Modified Source ↗
resilience announces appointment of william s. marth rph. mba as chief executive officer ↗
Modified Source ↗
resilience announces equity investment from mubadala and funding of new biopharma manufacturing facility in the united arab emirates ↗
Modified Source ↗
resilience is proud to support cargo therapeutics novel allogeneic car t cell therapy ↗
Modified Source ↗
careers ↗
Let’s Connect ↗
Modified Source ↗
corporate compliance ↗
Modified Source ↗
events ↗
Modified Source ↗
events old ↗
Modified Source ↗
facilities blue ash ↗
Modified Source ↗
facilities request a tour ↗
Modified Source ↗
facilities toronto ↗
Modified Source ↗
facilities west chester ↗
Modified Source ↗
privacy policy ↗
Modified Source ↗
safety inquiries ↗
Modified Source ↗
terms of service ↗
Modified Source ↗
resilience to present at the 42nd annual j.p. morgan healthcare conference ↗
Modified Source ↗
developing new medicines through artificial intelligence ↗
Modified Source ↗
how digital twins help improve biomanufacturing quality and security ↗
How Integrated Data Systems Enhance Clinical Development and Manufacturing ↗
Modified Source ↗
on demand presentation improving cell line development in cho with a focus on product manufacturability ↗
Modified Source ↗
on demand video efficiency meets economy the power of single use chromatography in mab purification ↗
Modified Source ↗
on demand webinar optimize research and delivery of complex medicines using data insights ↗
Modified Source ↗
on demand webinar outsourced pharma capacity update drug substance ↗
Modified Source ↗
resilience announces joint venture with lifera in saudi arabia ↗
Modified Source ↗
resilience appoints bill marth as president of services ↗
Modified Source ↗
resilience appoints dr. susan billings chief commercial officer ↗
Modified Source ↗
resilience builds lab supply chain tracking platform on aws ↗
Modified Source ↗
starburst data rebel awards data product of the year ↗
Modified Source ↗
bluebird bio and resilience announce strategic alliance to develop next generation cell therapies ↗
Modified Source ↗
boston ma process analytical development and manufacturing facility ↗
Modified Source ↗
bridgebio and resilience announce strategic multi year partnership ↗
Modified Source ↗
finish timelines your guide to quality and regulatory success in the cdmo space ↗
Modified Source ↗
cdmos are making their supply chains more resilient secure ↗
Modified Source ↗
fireside chat with rahul signhvi ceo of resilience ↗
Modified Source ↗
how an east bay site may lead a biotech manufacturing revolution ↗
Modified Source ↗
how resilience is bringing forward thinking to disrupt the biomanufacturing landscape to increase access to medicines ↗
Modified Source ↗
meet the 24 biotech startups that top vcs say are poised to take off in the next 12 months ↗
Modified Source ↗
national resilience honored by goldman sachs for entrepreneurship ↗
Modified Source ↗
finish solutions presentation ↗
Modified Source ↗
on demand video idea to clinic aim to reduce your manufacturing timeline by 30 ↗
Modified Source ↗
on demand webinar establishing a stage gate approach to biomanufacturing ↗
Modified Source ↗
on demand webinar future proof your aseptic filling ↗
Modified Source ↗
problem solving for aseptic filling ↗
Modified Source ↗
raging at the pandemic a vc raises 800m for a company that aims to transform biotech manufacturing ↗
Modified Source ↗
resilience acquires swiftscale biologics a leader in cell free protein synthesis technology ↗
Modified Source ↗
resilience and harvard university announce five year rd alliance to incubate new technologies launch companies to advance the manufacture of complex medicines ↗
Modified Source ↗
resilience and jobsohio announce continued partnership and expansion in blue ash ↗
Modified Source ↗
resilience and md anderson launch joint venture to accelerate development and manufacturing of innovative cell therapies for cancer ↗
Modified Source ↗
resilience and taiwan bio manufacturing corporation announce groundbreaking partnership in biomanufacturing innovation ↗
Modified Source ↗
resilience announces 625 million series d financing to expand network bring innovative technologies to biomanufacturing ↗
Modified Source ↗
resilience announces collaboration to manufacture and deliver biotherapeutics for rare and complex conditions ↗
Modified Source ↗
resilience announces expansion in west chester ↗
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy ↗
Modified Source ↗
resilience approved for 410m financing from the department of defense to establish resilient biomanufacturing capacity ↗
Modified Source ↗
resilience bags sanofi genzyme plant in boston ↗
Modified Source ↗
resilience becomes biomanufacturing resource partner for california institute for regenerative medicine ↗
Modified Source ↗
resilience continues expansion with acquisition of biologics manufacturing company ology bioservices ↗
Modified Source ↗
resilience establishes multi product development and manufacturing collaboration with takedas plasma derived therapies business unit ↗
Modified Source ↗
resilience expands clinical and commercial drug product manufacturing capabilities and capacities ↗
Modified Source ↗
resilience expands north american capacity with the acquisition of two premier biologics manufacturing facilities ↗
Modified Source ↗
resilience joins forces with childrens hospital of philadelphia to develop next generation biomanufacturing technologies create impactful therapies ↗
Modified Source ↗
resilience launches to change the future of medicine through manufacturing innovation ↗
Modified Source ↗
resilience partners with parvus therapeutics for development and manufacturing of pvt401 a novel autoimmune drug candidate for ibd ↗
Modified Source ↗
resilience receives usd 164 million investment from the government of canada to modernize and expand its ontario biomanufacturing site ↗
Modified Source ↗
resilience signs multi year strategic biomanufacturing partnership with leading pharmaceutical company ↗
Modified Source ↗
resilience subsidiary ology bioservices awarded contract worth up to 250 million from u.s. department of defense for botulinum neurotoxin treatment ↗
Modified Source ↗
resilience to establish a biomanufacturing partnership with astrazeneca and purchase astrazenecas manufacturing site in west chester ohio ↗
Modified Source ↗
resilience to manufacture mrna for modernas covid 19 vaccine ↗
Modified Source ↗
revised annex 1 and the focus on microbial control strategies ↗
Modified Source ↗
sanofi prepares to transfer allston plant to a new company but not its city tax breaks ↗
Modified Source ↗
the stage gate model a proven approach to streamline biomanufacturing ↗
Modified Source ↗
with stars aligned and cash in reserve bob nelsens resilience plans a makeover at 2 new facility additions to its drug manufacturing upstart ↗
Modified Source ↗
american biomanufacturing summit 2025 ↗
Modified Source ↗
asgct 2025 ↗
Modified Source ↗
atw 2025 ↗
Modified Source ↗
bio international convention 2025 ↗
Modified Source ↗
biomanufacturing world summit bmws 2025 ↗
Modified Source ↗
bioprocess international 2025 ↗
Modified Source ↗
bioprocess international 2026 ↗
Modified Source ↗
biotech showcase 2025 ↗
Modified Source ↗
car tcr summit 2025 ↗
Modified Source ↗
contract pharma 2025 ↗
Modified Source ↗
cphi worldwide 2025 ↗
Modified Source ↗
dcat week 2025 ↗
Modified Source ↗
jp morgan 2025 ↗
Modified Source ↗
advanced therapies week ↗
Modified Source ↗
american biomanufacturing summit ↗
Modified Source ↗
biomanufacturing world summit ↗
Modified Source ↗
biotech showcase ↗
Modified Source ↗
cdmo live americas ↗
Modified Source ↗
contract pharma 2026 ↗
Modified Source ↗
cphi worldwide ↗
Modified Source ↗
dcat week ↗
Modified Source ↗
jp morgan healthcare conference ↗
Modified Source ↗
massbio rd reimagined advanced modalities ↗
Modified Source ↗
offline ↗
Modified Source ↗
knowledge ↗
Modified Source ↗
kb 404 ↗
Modified Source ↗
kb search results ↗
Modified Source ↗
news ↗
Modified Source ↗
blog 25 test ↗
Modified Source ↗
events 25 test ↗
Modified Source ↗
news 25 test ↗
Modified Source ↗
offerings test ↗
Brand colors & fonts
Observed website styles · partial · Nov 11, 2026
accent · inferred
Source ↗background · inferred
Source ↗border · inferred
Source ↗background · inferred
Source ↗text · inferred
Source ↗background · inferred
Source ↗text · inferred
Source ↗text · inferred
Source ↗text · inferred
Source ↗background · inferred
Source ↗text · inferred
Source ↗Inter
body · declared in stylesheet · 400, 600, 700
Fallback: system-ui, sans-serif
Merriweather
heading · declared in stylesheet · 700, 400, 600
Fallback: system-ui, sans-serif
Inter
heading · declared in stylesheet · 400, 600, 700
Fallback: system-ui, sans-serif
Inter
ui · declared in stylesheet · 400, 600, 700
Fallback: system-ui, sans-serif
Inter
other · declared in stylesheet · 400, 600, 700
Fallback: system-ui, sans-serif
Disclaimer: These samples are not verified official brand guidelines or a complete palette. Previews use system fonts; font licensing, reuse and redistribution rights are unverified. Font URLs are evidence only. Actual rendering and loaded fonts may differ; displayed font names may be simplified.
Collection details
CSS declarations only; browser rendering, cascade, active theme, loaded fonts and official brand guidelines have not been verified. Generated font aliases are normalized for display; exact declarations remain in cssFamily. Colors are semantic declaration samples, not an exhaustive palette. Font asset URLs are evidence only; license and redistribution rights are unknown.